Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth | MicrobiomeTrials← Back to trialsNCT07815548
Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-09-10Est. Completion: 2027-11-30
Enrollment target: 222 participants Locations- Qilu Hospital of Shandong University, Jinan, Shandong, China
Other microbiome trials you might be interested in
Irritable Bowel Syndrome (IBS)Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
The goal of this clinical trial is to learn if an herbal supplement called Biocidin REMOVE can clear small intestinal ba…
Baltimore, United StatesEst. completion Dec 31, 2027
Small Intestinal Bacterial OvergrowthSIBO
The goal of this study is to test the effect of a probiotic formulation on gastrointestinal symptoms, gut and small inte…
Calgary, CanadaEst. completion Apr 2027